Prognostic value of baseline serum HER2 extracellular domain level with a cut-off value of 15 ng/mL in patients with breast cancer: a systematic review and meta-analysis Zhuo ZhangChao LiYimin Cui Review 29 August 2018 Pages: 513 - 521
Oncoplastic Breast Consortium consensus conference on nipple-sparing mastectomy Walter P. WeberMartin HaugMichael Gnant Review Open access 04 September 2018 Pages: 523 - 537
Surgical options for male breast cancer Ian S. Fentiman Review Open access 05 September 2018 Pages: 539 - 544
The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017: Egyptian view Hussein KhaledHeba GamalBeat Thürliman Review 14 September 2018 Pages: 545 - 550
IgA Fc-folate conjugate activates and recruits neutrophils to directly target triple-negative breast cancer cells Eric D. FronteraRafa M. KhansaCecilia L. Speyer Preclinical study 28 August 2018 Pages: 551 - 560
A tandem duplication of BRCA1 exons 1–19 through DHX8 exon 2 in four families with hereditary breast and ovarian cancer syndrome Chen DuDorothea MarkDoris Steinemann Preclinical study 06 September 2018 Pages: 561 - 569
Labour productivity loss caused by premature deaths associated with breast cancer: results from Spain over a 10-year period J. Oliva-MorenoL. M. Peña-Longobardo Preclinical study 12 September 2018 Pages: 571 - 576
CCN6 regulates IGF2BP2 and HMGA2 signaling in metaplastic carcinomas of the breast Emily R. McMullenMaria E. GonzalezCelina G. Kleer Preclinical study 15 September 2018 Pages: 577 - 586
Micro-computed tomography enables rapid surgical margin assessment during breast conserving surgery (BCS): correlation of whole BCS micro-CT readings to final histopathology David M. McClatchy IIIRebecca A. ZuurbierBrian W. Pogue Preclinical study Open access 17 September 2018 Pages: 587 - 595
Patients electing to have PET rather than surgery for operable breast cancer are a high risk of treatment failure Robert ThomasRachel RowellHenry Cain Clinical trial 29 August 2018 Pages: 597 - 601
Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927) Sherry ShenJoseph M. UngerDawn L. Hershman Clinical trial 29 August 2018 Pages: 603 - 610
Prediction of postoperative disease-free survival and brain metastasis for HER2-positive breast cancer patients treated with neoadjuvant chemotherapy plus trastuzumab using a machine learning algorithm Masahiro TakadaMasahiro SugimotoMasakazu Toi Clinical trial 07 September 2018 Pages: 611 - 618
Effects of trastuzumab on locoregional recurrence in human epidermal growth factor receptor 2-overexpressing breast cancer patients treated with chemotherapy and radiotherapy Seung Hyuck JeonKyung Hwan ShinSeock-Ah Im Clinical trial 12 September 2018 Pages: 619 - 626
Only estrogen receptor “positive” is not enough to predict the prognosis of breast cancer Jai Min RyuHee Jun ChoiSeok Won Kim Clinical trial 14 September 2018 Pages: 627 - 636
A portrait of germline mutation in Brazilian at-risk for hereditary breast cancer Ana Rafaela de Souza TimoteoAna Élida Menezes Magalhães GonçalvesTirzah Braz Petta Lajus Epidemiology 29 August 2018 Pages: 637 - 646
Obesity and mortality after locoregional breast cancer diagnosis A. Holliston MooreAmy Trentham-DietzSteven T. Fleming Epidemiology 29 August 2018 Pages: 647 - 657
Time to death in breast cancer patients as an indicator of treatment response Steven A. NarodVasily GiannakeasVictoria Sopik Epidemiology Open access 30 August 2018 Pages: 659 - 669
Tumor grade and progesterone receptor status predict 21-gene recurrence score in early stage invasive breast carcinoma Jing Li HuangScott KizyJane Yuet Ching Hui Epidemiology 08 September 2018 Pages: 671 - 677
High rate of occult cancer found in prophylactic mastectomy specimens despite thorough presurgical assessment with MRI and ultrasound: findings from the Hereditary Breast and Ovarian Cancer Registration 2016 in Japan Hideko YamauchiMegumi OkawaMasami Arai Epidemiology Open access 10 September 2018 Pages: 679 - 687
Young age at diagnosis is associated with worse prognosis in the Luminal A breast cancer subtype: a retrospective institutional cohort study Zhiyang LiuZeyad SahliChristopher B. Umbricht Epidemiology 17 September 2018 Pages: 689 - 702
Prognosis in patients diagnosed with loco-regional failure of breast cancer: 34 years longitudinal data from the Stockholm–Gotland cancer registry Claudette FalatoSara K. TaylorTheodoros Foukakis Epidemiology 17 September 2018 Pages: 703 - 712
Extracellular vesicles from triple-negative breast cancer cells promote proliferation and drug resistance in non-tumorigenic breast cells Patricia Midori Murobushi OzawaFaris AlkhilaiwiLuciane Regina Cavalli Brief Report Open access 01 September 2018 Pages: 713 - 723
Epigenetic modulation of FOXM1-gene interacting network by BET inhibitors in breast cancer Javier Pérez-PeñaBalázs GyőrffyAlberto Ocaña Brief Report 11 September 2018 Pages: 725 - 732
Effectiveness and tolerability of neoadjuvant pertuzumab-containing regimens for HER2-positive localized breast cancer Laura SpringAndrzej NiemierkoAditya Bardia Brief Report 15 September 2018 Pages: 733 - 740
Theoretical possibility of primary breast cancer originates from ectopic breast tissue in axillary lymph nodes Jiqiao YangQing Lv Letter to the Editor 27 August 2018 Pages: 741 - 742
Challenge for identifying the origin of occult breast cancer for optimizing local therapy Mitsuo Terada Rebuttal Letter 15 October 2018 Pages: 743 - 744
